PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
|
|
|
- Kory Cummings
- 5 years ago
- Views:
Transcription
1 1 Agio Pharmaceuticals Limited 15/31/2013-EP(Engg) dt: ,98, Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg) dt: ,10, Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg) dt: ,54, Alembic Pharmaceuticals Limited 15/31/2013-EP(Engg) dt: ,29, Apex Laboratories Private Limited 15/31/2013-EP(Engg) dt: ,52, Aristo Pharmaceuticals Pvt. Ltd 15/21/2012-EP(Engg) dt: , Aristo Pharmaceuticals Pvt. Ltd 15/31/2013-EP(Engg) dt: , Aristo Pharmaceuticals Pvt. Ltd 15/31/2013-EP(Engg) dt: ,13, Astra Lifecare (India) Pvt. Ltd 15/31/2013-EP(Engg) dt: ,20, Auctus Pharma Limited 15/31/2013-EP(Engg) dt: , Aurobindo Pharma Ltd 15/31/2013-EP(Engg) dt: /21/2012-EP(Engg) dt: ,39, Bio Medicare (India) Pvt. Ltd 15/31/2013-EP(Engg) dt: ,68, Biomedicare (India) Pvt. Ltd 15/31/2013-EP(Engg) dt: ,77, Cadila Healthcare Limited 15/31/2013-EP(Engg) dt: ,46,003.00
2 15 Centaur Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg) dt: ,41, Chempro Pharma Private Limited 15/21/2012-EP(Engg) dt: , Combitic Global Caplet Pvt. Ltd 15/31/2013-EP(Engg) dt: ,09, Corona Remedies Pvt. Ltd 15/31/2013-EP(Engg) dt: ,05, Cosme Pharma Limited 15/31/2013-EP(Engg) dt: ,24, Edge Pharma Private Limited 15/31/2013-EP(Engg) dt: ,78, Euro Life Healthcare Pvt. Ltd 15/31/2013-EP(Engg) dt: ,82, Fourrts (India) Laboratories Pvt Limited Fourrts (India) Laboratories Pvt. Limited 15/31/2013-EP(Engg) dt: ,76, /31/2013-EP(Engg) dt: ,68, Gepach International 15/31/2013-EP(Engg) dt: ,59, Ind-Swift Laboratories Limited 15/31/2013-EP(Engg) dt: ,29, Ind-Swift Limited 15/31/2013-EP(Engg) dt: , Infugen Pharma Pvt. Ltd 15/31/2013-EP(Engg) dt: ,77, J.B. Chemicals & Pharmaceuticals Ltd 15/31/2013-EP(Engg) dt: ,98,772.00
3 29 J.B. Chemicals & Pharmaceuticals Ltd 15/31/2013-EP(Engg) dt: ,50, Jmb Pharmaceuticals 15/31/2013-EP(Engg) dt: , Kusum Heatlhcare Pvt. Ltd 15/31/2013-EP(Engg) dt: ,75, Laurus Labs Pvt Ltd 15/31/2013-EP(Engg) dt: ,33, Libra Drugs (India) 15/31/2013-EP(Engg) dt: , Macleods Pharmaceuticals Limited 15/31/2013-EP(Engg) dt: ,26, Macleods Pharmaceuticals Ltd 15/31/2013-EP(Engg) dt: ,46, Msn Laboratories Pvt Ltd 15/31/2013-EP(Engg) dt: ,53, Mylan Laboratories Limited 15/31/2013-EP(Engg) dt: ,41, Naprod Life Sciences Pvt. Ltd 15/21/2012-EP(Engg) dt: ,25, Neuland Laboratories Limited 15/31/2013-EP(Engg) dt: ,51, Nexgen Healthcare Pvt. Ltd 15/31/2013-EP(Engg) dt: , Nirma Limited 15/21/2012-EP(Engg) dt: ,91, Nirma Limited 15/31/2013-EP(Engg) dt: ,53,939.00
4 43 Nirma Limited 15/31/2013-EP(Engg) dt: ,31, Nosch Labs Private Limited 15/31/2013-EP(Engg) dt: ,07, Ombiotec 15/31/2013-EP(Engg) dt: ,73, Parabolic Drugs Ltd 15/31/2013-EP(Engg) dt: ,90, Perdaman Pharmaceuticals Pvt. Ltd 15/31/2013-EP(Engg) dt: ,42, Protech Biosystems Pvt. Ltd 15/31/2013-EP(Engg) dt: ,35, Psa Chemicals & Pharmaceuticals 15/31/2013-EP(Engg) dt: ,24, R.S. Bhargava Pharmacy 15/31/2013-EP(Engg) dt: , Rhydburg Pharmaceuticals Ltd 15/31/2013-EP(Engg) dt: ,63, Rhydburg Pharmaceuticals Ltd 15/31/2013-EP(Engg) dt: , Rhydburg Pharmaceuticals Ltd 15/31/2013-EP(Engg) dt: ,18, S.R. Medicare (Pvt) Ltd 15/31/2013-EP(Engg) dt: ,57, Sava Medica Limited 15/31/2013-EP(Engg) dt: ,12, Sentiss Pharma Private Limited 15/31/2013-EP(Engg) dt: ,305.00
5 57 Sg Pharma Pvt. Ltd 15/31/2013-EP(Engg) dt: ,95, Sg Pharma Pvt. Ltd 15/31/2013-EP(Engg) dt: ,19, Shrey Nutraceuticals & Herbals Pvt. Ltd Shrey Nutraceuticals & Herbals Pvt. Ltd 15/31/2013-EP(Engg) dt: ,75, /31/2013-EP(Engg) dt: ,16, Simpex Pharma Pvt. Ltd 15/21/2012-EP(Engg) dt: , Simpex Pharma Pvt. Ltd 15/31/2013-EP(Engg) dt: ,22, Sirmaxo Chemials Pvt. Ltd 15/21/2012-EP(Engg) dt: , Sirmaxo Chemicals Pvt Ltd 15/31/2013-EP(Engg) dt: ,68, Sirmaxo Chemicals Pvt. Ltd 15/31/2013-EP(Engg) dt: ,69, Sr Medicare Pvt. Ltd. 15/31/2013-EP(Engg) dt: ,07, Torrent Pharmaceuticals Ltd 15/31/2013-EP(Engg) dt: ,74, Troikaa Pharmaceuticals Limited 15/31/2013-EP(Engg) dt: ,21, Troikaa Pharmaceuticals Ltd 15/31/2013-EP(Engg) dt: ,64, Vexta Laboratories Pvt Ltd 15/31/2013-EP(Engg) dt: ,20,547.00
6 71 Virchow Healthcare Private Limited 15/31/2013-EP(Engg) dt: ,31, Virchow Healthcare Pvt. Ltd 15/31/2013-EP(Engg) dt: , Zest Pharma 15/31/2013-EP(Engg) dt: ,35, Total 3,78,53,161.00
LETTERS FOR ISSUE ON
S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 04.10.2017 MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14608 QUERY 2. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14609 QUERY 3. DR. ULHAS
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
Disbursement of MDA Claims to Individual Exporters during (-11) 1 JPN Pharma API China 80,000.00 2 Unique Biotech Limited Bio May 3-6, 80,000.00 3 Titan Biotech Limited Cphi Japan 21st to 23rd April 80,000.00
LETTERS FOR ISSUE ON
S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC
TODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
List of Ordinary Members as on NAME OF THE COMPANY 1 AADIVIGHNESH CHEM PVT LTD 2 AANJANEYA LIFECARE LTD 3 AARTI DRUGS LTD 4 ACCENT
Sl No NAME OF THE COMPANY 1 AADIVIGHNESH CHEM PVT LTD 2 AANJANEYA LIFECARE LTD 3 AARTI DRUGS LTD 4 ACCENT MICROCELL INDUSTRIES 5 ADLIFE HEALTHCARE PVT. LTD. 6 AKUMS DRUGS & PHARMACEUTICALS LTD 7 ALCON
LETTERS FOR ISSUE ON
S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE
LETTERS FOR ISSUE ON
S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.
LETTERS FOR ISSUE ON
S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL
LETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 27.12.2017 LVP DIVISION S. NO. COMPANY NAME FTS NO. /Diary No. STATUS 01 M/s. Akums Drugs & Pharmaceuticals, Haridwar 02 M/s. Unique Pharmaceutical Laboratories,Guj. (License No.4)
LETTERS FOR ISSUE ON
S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,
LETTERS FOR ISSUE ON
S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY
LETTERS FOR ISSUE ON
S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL
RESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33
Computataion of Retail Price based on Jan.-2016 Data under Para 4 of DPCO 2013 Cholecalciferol 800 IU Drops of M/s Raptakos, Brett & Co.Ltd. Number of Companies cosisting of Market Share of 1% & Above
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.05.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH MUMBAI-400709 2. M/S. ACCUTEST RESEARCH MUMBAI-400709 3. M/S. ACCUTEST RESEARCH MUMBAI-400709
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application
ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules
Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules The prices listed below are Average Wholesale Prices ( AWP ) as established and made
Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
Case 3:15-cv-05982-PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 Liza M. Walsh Christine I. Gannon CONNELL FOLEY LLP One Newark Center 1085 Raymond Boulevard, 19th Floor Newark, New Jersey
LETTERS FOR ISSUE ON
S FOR ISSUE ON 19.06.2015 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 2. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT.,
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the
Education. Current Activities
Nirali Mehta, M.Sc., M.Phil. Founder & Consultant Biostatistician Ahmedabad, Gujarat, India. M +91 9377060504 E nirali.mehta@pharma-stats.in W www.pharma-stats.in Education 1998-2001 Bachelor of Science
NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,
What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations
List of Ordinary Members as on NAME OF THE COMPANY 1 Aadivignesh Chem Pvt Ltd 2 Aanjaneya Lifecare Ltd 3 Aarti Drugs Limited 4 Adlife
List of Ordinary Members as on 03.08.2012 Sl No NAME OF THE COMPANY 1 Aadivignesh Chem Pvt Ltd 2 Aanjaneya Lifecare Ltd 3 Aarti Drugs Limited 4 Adlife Healthcare Pvt Ltd 5 Aja Pharmachem 6 Ajanta Pharma
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY
New Delhi, the 18 th December, 2017 ORDER
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division
Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution
State of Industry Readiness for the New Demand Following the New Treatment Guidelines
JOINT MEDICINES PATENT POOL & WHO SATELLITE ON BRIDGING THE NEW TREATMENT GAP: WHAT WILL IT TAKE? State of Industry Readiness f the New Demand Following the New Treatment Guidelines Louis J. Riceberg,
LETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
Information for Vermont Prescribers of Prescription Drugs. Lunesta (eszopiclone tablets)
Information for Vermont Prescribers of Prescription Drugs Lunesta (eszopiclone tablets) This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety.
Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023
Case 1:14-cv-00121-LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABO RA TORIES, INC., FOREST LABO RA TORIES HOLDINGS,
REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
ARTIFICIAL SWEETENERS: A MARKET WATCH
ARTIFICIAL SWEETENERS: A MARKET WATCH BARPETE P. K. 1 *, SINGH S. 2 1, Malhotra College of Pharmacy, Bhopal, M.P-India 2, Dabur Pharma, Delhi-India ABSTRACT Artificial sweeteners are so much sweeter than
PROVISIONAL RATE LIST FOR NIT 120 (Pharma)
all 1 120003 Acenocoumarol/Nicoumalone Tablet 2 mg 10 x 10 15,000 L1 CIRON DRUGS AND PHARMACEUTICALS PVT LTD 259.0004 259.0004 L2 ABBOTT HEALTHCARE PRIVATE LIMITED 386.66 405.993 2 Adrenochrome Monosemicarbazone
NATIONAL DRUG REGISTER OF UGANDA HERBAL HUMAN FEBRUARY 2018
NATIONAL DRUG REGISTER OF UGANDA HERBAL HUMAN FEBRUARY 2018 LICENSE No NDA/MAL/HHP/80 94 LICENSE HOLDER BHARGAVA PHYTOLAB PVT. LTD LOCAL TECHNICAL REPRESENTATIVE PRODUCT NAME AND BRAND POSTORAL GAMA SILYBIN
The Eden Gardens Group of Companies Experience. Presented by: Prof. the Hon. Henry Lowe, O.J., C.D., J.P., Ph.D., DSc(Hon) F.R.S.
Monetizing the Plant-based Medicine Industry The Eden Gardens Group of Companies Experience Group The Eden Gardens Group of Companies: Eden Gardens Wellness Resort & Spa, Bio-Tech R&D Institute, EG Wellness
STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th JANUARY, Pack Size. Vial.
1 STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th JANUARY, 2001 Agenda Item No. Company Name/ Formulation Name/Composition Pack Size Existing Price RP
WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract Research Organization
SOP 408.4 Annex C 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int Part 1: General information WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract
Cost analysis of antifungal drugs available in India: A pharmacoeconomic perspective
Original Research Article DOI: 10.18231/2393-9087.2016.0013 Cost analysis of antifungal drugs available in India: A pharmacoeconomic perspective Ashutosh Tiwari 1,*, Pooja Reddy 2, Chhaya Goyal 3 1 Tutor,
Enforcement Report - Week of May 2, 2018
Enforcement Report - Week of May 2, 2018 Class I Event 79555 03/15/2018 04/24/2018 Press Release Bayer HealthCare Pharmaceuticals, Inc. 100 Bayer Blvd Whippany NJ United States Nationwide in the USA All
Patel Krunal M et al. IRJP 2 (2)
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN 223 87 Available online http://www.irjponline.com Research Article DESIGN DEVELOPMENT AND EVALUATION OF MODIFIED RELEASE TABLET OF MONTELUKAST SODIUM BY
TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.
Number of Companies consisting of Market Share of 1% & Above 2 3.1 Adrenaline Injection 1 mg/ml Per ml Sum of MAT value considered for price calculation (in Lakhs) 152.69 Sum of PTR per unit considered
10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE
10 th SEC- (Reproductive & Urology)meetingheld on 16-01-2015 at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi 110 002 PROGRAMME SCHEDULE Recommendation:- The 10 th SEC (Reproductive and Urology) meeting
QUANTITY LIMIT CRITERIA
DRUG CLASS INHALATION BRAND NAME (generic) QUANTITY LIMIT CRITERIA SHORT ACTING BETA2-ADRENERGIC AGONIST ORAL (albuterol inhalation solution) PROAIR HFA PROAIR RESPICLICK PROVENTIL HFA VENTOLIN HFA XOPENEX
Medicines availability short-term supply issues Last updated 01/05/18
Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is
Integrative Healthcare Symposium Annual Conference 2016 Exhibitor List
Integrative Healthcare Symposium Annual Conference 2016 Exhibitor List If you are a current attendee or exhibitor and would like access to the interactive exhibitor list, please email info@ihsymposium.com.
MEDICATION GUIDE Levetiracetam (LEE-ve-tye-RA-se-tam) Extended-Release Tablets, USP Rx Only
MEDICATION GUIDE Levetiracetam (LEE-ve-tye-RA-se-tam) Extended-Release Tablets, USP Rx Only Read this Medication Guide before you start taking levetiracetam extended-release tablets and each time you get
Global Nutraceuticals Market
Published on NOVONOUS (https://www.novonous.com) Home > Global Nutraceuticals Market 2016-2020 Global Nutraceuticals Market 2016-2020 Publication ID: NOV1016004 Publication Date: October 14, 2016 Pages:
Information for Vermont Prescribers of Prescription Drugs Long Form
Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF JUNE-2016 DATE OF HEARING 13.06.2016 1. 934855/05 Opp. AMD-245342 M/s. Ajanta Pharma Limited, Mumbai / Mr. Manoj G. Menda, Mumbai
BRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
Laurus Labs Ltd (Laurus) -API leadership & R&D to drive growth
Laurus Labs Ltd (Laurus) -API leadership & R&D to drive growth 1 April 2018 Laurus Labs Ltd (Laurus) 31-03-2018 Recommendation : Buy CMP : Rs 503.00 Target : NA % Allocation : 5% Sector : Pharmaceuticals
Anurag Agarwal Chief Operating Officer Natural Remedies Pvt Ltd. Bangalore
I ndian Herbals Global opportunities Anurag Agarwal Chief Operating Officer Natural Remedies Pvt Ltd. Bangalore Time : Date : 28 th June, 2007 16.00 pm to 17.30 pm Venue: Hotel Marriot, Hyderabad WORLD
NUTRACEUTICALS / NATURAL PRODUCT
NUTRACEUTICALS / NATURAL PRODUCT: HOW TO BRING THEM TO HIGHER CLAIMS @ BIO-BORNEO-2015 Dr. RAVI K. B B.V.Sc & AH., M.V.Sc (ARGO). COO and Test Facility Management MyBioscience Lab Sdn. Bhd., Melaka, Malaysia.
Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-
Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on 05.11.2014 and recommended the following:- Agend a No. File No. 1. File No.: 12-75/13-DC Afatinib film coated tablet
RESEARCH PERFORMANCE ON ALOE VERA: A SCIENTOMETRIC ANALYSIS
International Journal of Library & Information Science (IJLIS) Volume 6, Issue 6, November December 2017, pp. 60 67, Article ID: IJLIS_06_06_008 Available online at http://www.iaeme.com/ijlis/issues.asp?jtype=ijlis&vtype=6&itype=6
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
Statement showing the Item wise BFC Approved list for TNo.2/TSMSIDC/Medicines/ , Dt
Statement showing the Item wise BFC Approved list for TNo.2/TSMSIDC/Medicines/2016 18, Dt.24.05.2016 Sl. No Code Group Item Name Firm Name Unit L1 Rate 1 2193 EML Aceclofenac 100mg Tab Deepin Pharmaceuticals
Global Aspergillosis Drugs Market Professional Survey Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24
Pelagia Research Library. Spectrophotometric method for simultaneous estimation of Valsartan and Hydrochlorothiazide in combined tablet dosage form
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2011, 2 (3): 123-130 ISSN: 0976-8688 CODEN (USA): PSHIBD Spectrophotometric method for simultaneous estimation of Valsartan and
Produced by The Kidney Foundation of Canada
31 HELPFUL HINT Become an expert on all the medications you re taking. You should know: Name of medication Strength of medication Dose (how much to take) How often and what time of day to take it What
Integrative Healthcare Symposium Annual Conference 2016 Exhibitor List
Integrative Healthcare Symposium Annual Conference 2016 Exhibitor List If you are a current attendee or exhibitor and would like access to the interactive exhibitor list, please email info@ihsymposium.com.
The Soft Gel Specialist
Renown PHARMACEUTICALS PVT. LTD. The Soft Gel Specialist Prestigious History Welcome to Renown Pharmaceuticals Demand for Soft Gelatin Capsules is ever increasing for Nutraceuticals, Cosmetics and Herbals.
+91-8042964906 Streamline Pharma Private Limited http://www.herbalmedicinesonline.in/ With the support of vast knowledge, we are recognized as a noteworthy manufacturer, supplier and service provider of
Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube
Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube On Aug. 24, 2015, Allergan recalled three lots (86258 expires September 2017, 87189 December 2017 and 87514 February
extracts from India The World Health Organization (WHO) estimates 4 billion people use herbal medicine.
World Class Botanicals extracts from India Presented by: Madhu.K Team Leader International Business Remedies Pvt Lts Bangalore madhu@naturalremedy.com, www.naturalremedycom Remedies Solutions for Healthy
+91-8046055750 Rajasthan Aushadhalaya Private Limited http://www.rajasthanherbalsinternational.com/ A proficient formulator of a broad array of ayurvedic & pharmaceutical medicines as well as cosmetic
Research Article Comparative study of efficacy of Ayurvedic Appetizer formulations in experimental animals
Research Article Comparative study of efficacy of Ayurvedic Appetizer formulations in experimental animals Chintaman Kumawat *, Anis Shaikh, Vandana Wadia, Arpan Bhardwaj and Tanu Bhargava SPTM, NMIMS
Preliminary Bid Evaluation. Tender No: DME / 3 / Dialysis/2016 / Dated: 15 /12 /2016.
Preliminary Bid Evaluation Tender : DME / 3 / Dialysis/2016 / Dated: 15 /12 /2016. Date of bid opening: 19.01.2017 S. Name of the Bidder: M/s. Apex Kidney Care M/s. Apex Kidney Care 1 Process Fee 10,000/-
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets This list does not imply that the products on this chart are interchangeable
Streamline Pharma Private Limited
+91-8048603298 Streamline Pharma Private Limited https://www.indiamart.com/streamlinepharma-p-ltd/ Streamline Pharma pvt. Ltd. is domestic supplier of herbal health care products that cause no side effects.
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF SPTEMBER-2013 DATE OF HEARING 10.09.2013 R. T. M. 1. 842945/16 Rect. AMD-249059 Mr. Pankajbhai Sitaram Nayak, Hearing on Section
The State Pharmacopoeia of the Russian Federation
The State Pharmacopoeia of the Russian Federation XII Edition Part 1 Current state and strategy for the future Before 12 th edition of the State Pharmacopoeia of the Russian Federation there were following
Recent trends and challenges
INTERNATIONAL CONFERENCE ON Recent trends and challenges in Bioanalysis Tentative Program Bioanalytica-2017 Hyderabad,India JUNE 30, 2017 Invitation ABC Biologics welcomes you to attend the international
Vol-3, Issue-4, Suppl-1, Nov 2012 ISSN: Patel et al PHARMA SCIENCE MONITOR
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR ALOE POLYSACCHARIDES AS A MEASURE OF ALOE VERA QUALITY IN HERBAL FORMULATION
3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore.
MINUTES OF THE 6 th MEETING OF TECHNICAL COMMITTEE HELD ON 25-07-2013 UNDER CHAIRMANSHIP OF DGHS FOR SUPERVISING CLINICAL TRIALS ON NEW CHEMICAL ENTITIES IN THE LIGHT OF DIRECTIONS OF THE HON BLE SUPREME
Name of firm/applicant. Torrent Pharmaceuticals. Glenmark Pharmaceuticals. M/s. Torrent Pharmaceutical. Torrent Pharmaceuticals
Recommendation:- The 14 Th SEC (Cardiovascular & Renal) deliberated the proposals on 21.08.2014 and recommended the following:- Agenda no. File no Name of firm/applicant Recommendations 1. 04-228/06-D(pt
Alvizia Healthcare Private Limited
+91-8048413356 Alvizia Healthcare Private Limited https://www.alviziahealthcare.net/ We are one of the leading manufacturers, wholesaler and traders of the Pharmaceutical Products. Owing to their rich
ISF College of Pharmacy Total No. of Publications (2015): 35
Sr No. Title Authors Journal Name, Year, Vol., Page no. Sharma A, Anghore D, World J Pharm. Pharmaceu. Sci. Awasthi R, Kosey S, Jindal S, 2015; 4(12): 1088-1113. Gupta N, Raj D, Sood R 1. A review on current
Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.
Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Product Number API Test product Dose/ mg Manufacturer Country of manufacture Country
An Overview on the Global Market of Dietary Supplements
An Overview on the Global Market of Dietary Supplements Abbas Kebriaeezadeh 1 and Alireza Yektadoost 2 Department of Pharmacoeconomics & Pharmaceutical Administration Faculty of Pharmacy, Tehran University
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
Media coverage. Sohum Newborn Hearing Screening Device Product Launch. prokerala.com. Mon, Jul :45 IST. YS Chowdary launches 'Sohum
Media coverage Sohum Newborn Hearing Screening Device Product Launch prokerala.com Mon, Jul 17 2017 20:45 IST YS Chowdary launches 'Sohum New Delhi: Union MoS Science and Technology and Earth Sciences
Edmund Healthcare Pvt. Ltd.
+91-8048410921 Edmund Healthcare Pvt. Ltd. https://www.edmundhealthcare.in/ Our firm is ranked as the leading Trader and Supplier of a wide array of Pharmaceutical Injection, Pharmaceutical Tablets, Pharmaceutical
MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER, ELDERY & CHILDREN TANZANIA FOOD AND DRUGS AUTHORITY P.O.
MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER, ELDERY & CHILDREN TANZANIA FOOD AND DRUGS AUTHORITY P.O. Box 1253, Dodoma, Tanzania Tel: +255 22 2450751, +255 22 2450512, Fax: +255 22 2450793 Website:
Organ Transplantation Market Research Report- Global Forecast Till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/915 Organ Transplantation Market Research Report- Global Forecast Till 2023 Report / Search Code: MRFR/HC/0410-HCRR
Minimumum Price (Rs.) 6.93 Maximum Price (Rs.) Average of all considered (Rs.) 8.97 Retail Price (Rs.) 10.41
S. No. Computataion of Retail Price based on May, 2016 Data under Para 4 of DPCO 2013 ASPIRIN 75mg + ROSUVASTATIN 10mg + CLOPIDOGREL 75mg Tablet of M/s Safetab Life Science/M/s Intas Pharmaceuticals Ltd.
M/s. Hetero Labs Ltd.
:- The 1 st SEC (Gastroenterology&Hepatology) meeting deliberated the proposals on 06.01.2017 and recommended the following:- Agenda New Drugs Division Proposal 1 12-54/16-DC Sofosbuvir and Velpatasvir
NATIONAL DRUG REGISTER OF UGANDA HERBAL HUMAN JANUARY 2017 MANUFACTURER DRUG NAME REG NUMBER PACK SIZES DOSAGE FORM LICENCE HOLDER CTRY OF MAKE LTR
NATIONAL DRUG REGISTER OF UGANDA HERBAL HUMAN JANUARY 2017 MANUFACTURER DRUG NAME REG NUMBER PACK SIZES DOSAGE FORM LICENCE HOLDER CTRY OF MAKE LTR VITAL CARE VYBRANT 001/00 5 * 10, 10 BLISTER CAPSULE
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES COMPARATIVE ANTIDIABETIC ACTIVITY OF SOME HERBAL PLANTS EXTRACTS
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES COMPARATIVE ANTIDIABETIC ACTIVITY OF SOME HERBAL PLANTS EXTRACTS Patil Priyanka S 1., Patel M.M 2., Bhavsar C.J 3. 1 P.S.G.V.P.M
CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare
Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets
Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets The prices listed below are Average Wholesale Prices ( AWP ) as established and made available to the public